GBCCX
Price
$16.03
Change
+$0.22 (+1.39%)
Updated
Oct 20 closing price
Net Assets
19.45M
RMEBX
Price
$62.36
Change
+$0.51 (+0.82%)
Updated
Oct 20 closing price
Net Assets
111.18B
Interact to see
Advertisement

GBCCX vs RMEBX

Header iconGBCCX vs RMEBX Comparison
Open Charts GBCCX vs RMEBXBanner chart's image
Gabelli Dividend Growth C
Price$16.03
Change+$0.22 (+1.39%)
VolumeN/A
Net Assets19.45M
American Funds American Mutual R2E
Price$62.36
Change+$0.51 (+0.82%)
VolumeN/A
Net Assets111.18B
GBCCX vs RMEBX Comparison Chart in %
View a ticker or compare two or three
VS
GBCCX vs. RMEBX commentary
Oct 21, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GBCCX is a StrongBuy and RMEBX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RMEBX has more cash in the bank: 111B vs. GBCCX (19.5M). RMEBX pays higher dividends than GBCCX: RMEBX (1.05) vs GBCCX (0.00). GBCCX was incepted earlier than RMEBX: GBCCX (22 years) vs RMEBX (11 years). GBCCX (3.40) is less costly to investors than RMEBX (1.07). RMEBX is a more actively managed with annual turnover of: 31.00 vs. GBCCX (23.00). RMEBX has a lower initial minimum investment than GBCCX: RMEBX (250) vs GBCCX (1000). RMEBX annual gain was more profitable for investors over the last year : 4.81 vs. GBCCX (-3.18). RMEBX return over 5 years is better than : 55.95 vs. GBCCX (16.25).
GBCCXRMEBXGBCCX / RMEBX
Total Expense Ratio2.751.07257%
Annual Report Gross Expense Ratio3.401.07318%
Fund Existence22 years11 years-
Gain YTD10.71413.52779%
Front LoadN/AN/A-
Min. Initial Investment1000250400%
Min. Initial Investment IRAN/AN/A-
Net Assets19.5M111B0%
Annual Yield % from dividends0.001.05-
Returns for 1 year-3.184.81-66%
Returns for 3 years19.9538.1952%
Returns for 5 years16.2555.9529%
Returns for 10 years-5.1689.36-6%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
EXLS40.340.67
+1.69%
ExlService Holdings
T26.340.14
+0.53%
AT&T
GDRX3.83-0.07
-1.79%
GoodRx Holdings
ACIU2.90-0.06
-2.03%
AC Immune SA
FGEN10.38-0.39
-3.67%
FibroGen Inc